June 3 (Reuters) – Troubled Canadian drugmaker Valeant
Pharmaceuticals International Inc said it received
another notice of default from bondholders for the delay in
filing its first-quarter report.
The post Valeant gets another default notice from bondholders appeared first on NASDAQ.